好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

PRE-CELL: Clinical and Novel Biomarker Measures of Disease Progression in a Lead-In-Observational Study for a Planned Phase 1 Trial of Genetically-Modified Mesenchymal Stem Cells Over-Expressing BDNF in Patients with Huntington’s Disease
Movement Disorders
(-)
004
Authors/Disclosures
Vicki L. Wheelock, MD (UC Davis Department of Neurology)
PRESENTER
Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME Continuing Medical 好色先生.
No disclosure on file
Alexandra O. Duffy, MD, FAAN (UC Davis Health) Dr. Duffy has nothing to disclose.
No disclosure on file
No disclosure on file
Ashok J. Dayananthan, MD (Sutter Medical Group) No disclosure on file
No disclosure on file
Sarah Farias (University of California, Davis) No disclosure on file
No disclosure on file
Charles S. DeCarli, MD, FAAN (UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center) Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH.
James A. Brunberg, MD (UC Davis Medical Center) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Steven M. Hersch, MD, PhD (Eisai Inc.) Dr. Hersch has received personal compensation for serving as an employee of Eisai Inc.. Dr. Hersch has stock in Voyager Therapeutics. The institution of an immediate family member of Dr. Hersch has received research support from NIH. Dr. Hersch has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
No disclosure on file
Jan Nolta, PhD (University of California Davis) No disclosure on file